Abstract
Herein we describe the discovery of a novel series of pyrrolo[1,2-a]pyrazin-1(2H)-one PARP inhibitors. Optimization led to compounds that display excellent PARP-1 enzyme potency and inhibit the proliferation of BRCA deficient cells in the low double-digit nanomolar range showing excellent selectivity over BRCA proficient cancer cells.
Copyright (c) 2009 Elsevier Ltd. All rights reserved.
MeSH terms
-
Animals
-
BRCA1 Protein / deficiency
-
BRCA1 Protein / metabolism
-
Cell Line, Tumor
-
Crystallography, X-Ray
-
HeLa Cells
-
Humans
-
Indolizines / chemistry
-
Indolizines / metabolism
-
Microsomes, Liver / drug effects
-
Microsomes, Liver / enzymology
-
Poly (ADP-Ribose) Polymerase-1
-
Poly(ADP-ribose) Polymerase Inhibitors*
-
Poly(ADP-ribose) Polymerases / metabolism
-
Protein Binding / physiology
-
Pyrazines / chemistry*
-
Pyrazines / metabolism*
-
Rats
-
Structure-Activity Relationship
Substances
-
BRCA1 Protein
-
BRCA1 protein, human
-
Indolizines
-
Poly(ADP-ribose) Polymerase Inhibitors
-
Pyrazines
-
indolizine
-
PARP1 protein, human
-
Poly (ADP-Ribose) Polymerase-1
-
Poly(ADP-ribose) Polymerases